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Abstract The yeast Saccharomyces cerevisiae is likely to be the
first organism for which a complete inventory of mitochondrial
proteins and their functions can be drawn up. A survey of the 340
or so proteins currently known to be localised in yeast
mitochondria reveals the considerable investment required to
maintain the organelle’s own genetic system, which itself
contributes seven key components of the electron transport
chain. Translation and respiratory complex assembly are
particularly expensive processes, together requiring around 150
of the proteins so far known. Recent developments in both areas
are reviewed and approaches to the identification of novel
mitochondrial proteins are discussed.
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1. Introduction
Mitochondria are essential to all eukaryotic cells that use
oxygen. For reasons that are still unclear, the organelle has
retained its own genome, a remnant of the primitive endo-
symbiont that ¢rst colonised a predecessor of today’s eukar-
yotes. Mitochondrial assembly depends on balanced synthesis
of a handful of proteins encoded by mtDNA with several
hundred others encoded by nuclear genes. The inability to
assemble a functional mitochondrion underlies a wide spec-
trum of degenerative diseases in man. Despite an increasing
realisation of the extent of involvement of mutations in
mtDNA in both these diseases and aging, much has still to
be done on the characterisation of those diseases for which
dysfunction is the result of disturbances in the complex inter-
actions between mitochondrial- and nuclear-encoded compo-
nents of the respiratory chain. As an illustration, although
more than 50 disease-producing mutations in mtDNA have
been characterised, the nuclear genes involved still only run to
single ¢gures (see [1] for review).
Despite advances in other systems, the facultative anaerobic
yeast Saccharomyces cerevisiae still remains a highly attractive
experimental organism for the study of mitochondrial assem-
bly. Respiratory functions are dispensable as long as cells can
fall back on glycolysis as a source of energy and intermedi-
ates. This means that mutations a¡ecting synthesis or function
of respiratory chain components are viable and that levels of
these components can be manipulated simply by changes in
culture conditions. The availability of full genomic sequence
data greatly facilitates the characterisation of mutations in
genes involved in mitochondrial function or assembly, the
identi¢cation of novel mitochondrial proteins and the ge-
nome-wide study of changes in gene expression. It is therefore
highly likely that yeast will be the ¢rst organism for which a
complete inventory of mitochondrial proteins and their func-
tions can be drawn up.
Since the publication of the complete genomic sequence of
S. cerevisiae in 1996, the number of genes known to encode
mitochondrial proteins has increased from just under 200 to
the current 340 (as of March 1999) out of a total gene comple-
ment of about 6100 (Table 1). Ongoing gene function analysis
programmes have thrown light on the nature and role of these
newly identi¢ed proteins and are opening novel routes to the
identi¢cation of additional ones. Aims of this minireview are
to survey this recent information in terms of the insight it
provides into the synthesis and assembly of the enzymes of
the respiratory chain and to assess the value of yeast as a test
bed for ideas about mitochondrial dysfunction in man and
other organisms.
2. The price of mitochondrial assembly
A rapid survey of information available in the Yeast Pro-
teome Database (YPD, [2]) shows that about 100 of the 340
known mitochondrial proteins are located in the inner mem-
brane, with 15 in the outer membrane. Major functional
classes include proteins of the ribosome (63); transporters of
the mitochondrial carrier family (MCF; up to 35); proteins
involved in translational activation (11) and respiratory en-
zyme assembly (26, including ¢ve members of the triple-A
family).
Altogether, some 127 of these 340 proteins are components
of the mitochondrion’s own genetic machinery, being directly
involved in either maintenance of mtDNA or a subsequent
step in gene expression. This ¢gure forcibly emphasises the
considerable investment required to maintain the organelle’s
own genetic system and the ability to synthesise the mere
seven respiratory chain proteins encoded by it.
Translation and respiratory complex assembly are particu-
larly expensive processes, together requiring around 150 pro-
teins. Both are still poorly understood, with many steps, even
those involving mRNA recognition or translational control,
occurring with the help of membrane-associated proteins. The
schematic overview presented in Fig. 1 indicates ¢ve broad
areas for which new insights have recently become available
and which will be discussed in more detail below.
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3. Processing, splicing and stabilisation of mRNAs
Both the presence of introns and the fact that many genes
in yeast mtDNA are co-transcribed mean that processing is an
important feature of gene expression. An important develop-
ment in the past year has been the unraveling of the so far
puzzling nature of the functional link between the MRS2 gene
and a number of other genes capable of suppression of the
respiratory de¢ciency caused by loss of its function. MRS2 is
required both for splicing of group II introns and for an as yet
unde¢ned function in (mainly) cytochrome c oxidase assembly
[3]. The gene encodes a membrane-associated protein that
contains short, but distinctive sequence motifs characteristic
of a family of bacterial divalent metal ion transporters. Recent
work by Schweyen and colleagues (R.J. Schweyen, personal
communication) now suggests that Mrs2p functions as a mi-
tochondrial Mg2 transporter. This neatly explaining its in-
volvement in Mg2-dependent RNA self-splicing and assem-
bly of at least cytochrome oxidase (each monomer of which
contains a Mg2 ion). It also accounts for the multi-copy
suppression of mrs20 mutants by membrane carriers like
Mrs3p and Mrs4p [4] and by Tim10p, Tim12p (Mrs5p,
Mrs7p [5]. The latter are components of the protein trans-
location machinery that speci¢cally interact with members
of the mitochondrial carrier family during their import into
the inner membrane.
Despite these successes, however, much has still to be re-
solved, with questions relating to mRNA stability heading the
list. Still far too little is known about the mitochondrial de-
gradosome ^ a complex responsible for the 3P-5P degradation
of almost all mRNAs and containing Suv3p and Dss1p to-
gether with the product of a third as yet unidenti¢ed gene [6].
The same can be said of a number of factors, which have
unde¢ned roles in mRNA-speci¢c stabilisation, sometimes
with additional (and unde¢ned) roles in other processes like
transcription (Nam1p/Mtf2p [7]), processing (Cbp1p, Pet127p
[8,9]), or translation (Pet309p [10])
4. Components of the translational machinery
The most recent head count of ribosomal proteins (MRPs)
in yeast mitochondria yields a grand total of 63 ^ modest in
comparison with the 136 of the cytoplasmic ribosome, but still
a large part of the high price paid for the luxury of an in-
dependent translation system. Whether this represents a com-
plete set is not yet clear. These proteins were identi¢ed by
either genetic means or direct protein sequencing and both
are ongoing approaches with plenty of scope for new discov-
eries. One of the most surprising features of the current set is
the relatively low degree of sequence conservation. Only a
minority displays signi¢cant sequence similarity to ribosomal
proteins from other sources [11]. Yeast and mammalian
MRPs are as much divergent as the latter are from Escherichia
coli ribosomal proteins [12] and only 10 MRPS in Caenorhab-
ditis elegans could be identi¢ed by a direct sequence compar-
ison with yeast [13]. What this means in functional terms is
hard to say. The lack of a faithful reconstituted in vitro trans-
lation system in mitochondria of any kind still represents a
barrier to further progress in this area.
5. Translational activation
Synthesis of the mitochondrially encoded components of
the yeast respiratory chain is unusual in its requirement for
subunit-speci¢c translational activators. Those required for
Table 1
The price of mitochondrial assembly (March 1999)
Category Number
Known mitochondrial proteins 340
Involved in biogenesis and assembly 176
Mitochondrial gene expression 127
MtDNA maintenance 10
RNA processing 20
Translation 97
The table sums nuclear genes currently known to be involved in mi-
tochondrial assembly and maintenance of the mitochondrial genetic
system in yeast (based on information available in the YPD data-
base (http://proteome.com/YPDhome.html).
Fig. 1. Factors required for respiratory complex assembly in yeast. The ¢gure presents a non-exhaustive overview of proteins involved at vari-
ous stages of the synthesis and assembly of mitochondrial gene products into a functional respiratory chain. Genes listed in bold print display
evolutionary conservation of sequence. Additional information on individual proteins can be obtained by consultation of the YPD database
(http:// proteome.com/YPDhome.html). See text for discussion.
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Cox1, Cox2, Cox3 and Cytb synthesis are genetically the best
characterised [14]. Their action is dependent on the presence
of speci¢c sequences in the 5P-untranslated leaders of the re-
spective mRNA. Several display additional interactions with
the mitochondrial ribosome; some are integral membrane
proteins. In one case (COX3), the amount of at least two
activators (Pet122p and Pet494p) appears to be limiting and
thus could exert control on synthesis [15,16]. Recent work [17]
suggests that these properties usefully combine to e¡ectively
tether ribosomes and translated mRNAs to the inner mem-
brane, thereby plausibly facilitating the co-translational inser-
tion of newly synthesised polypeptides into the membrane. In
support of this idea, the same authors also show that inap-
propriate synthesis in the mitochondrial matrix results in Cox
polypeptides that turn over rapidly. This model blurs some-
what the distinction between a translational activator and
assembly factor. It invites questions such as (1) why should
di¡erent subunits of a single enzyme require di¡erent activa-
tors; (2) do factors with corresponding functions exist in the
metazoa whose mitochondria contain mRNAs mostly lacking
in 5P-UTRs? None of the yeast proteins displays a particularly
strong conservation of sequence, making identi¢cation of
counterparts in even quite closely related yeasts and fungi
di⁄cult [18] and in other organisms almost impossible.
Not all translational activators obviously depend on a 5P-
UTR for their action. So far, unlike other translational acti-
vators, no mitochondrial 5P-leader rearrangements have been
found to suppress mutations in MSS51, a gene encoding a
membrane-bound putative translational activator for Cox1
mRNA ([19]; M. Siep and H. van der Spek, unpublished
observation). This may mean that Mss51p does not act via
direct interaction with the 5P-UTR, or simply that the right
rearrangements have yet to be found. Unlike other transla-
tional activators, Mss51p may be present in appreciable ex-
cess. The mss51-3 mutant [19], which produces a wild type
protein at around 1% or less of wild type levels is capable
of restoring 10^20% of wild type CoxI synthesis to an
mss51‡ mutant (M. Siep, H. van der Spek and L.A. Grivell,
in preparation).
6. Quality control
Somewhat speculatively shown in Fig. 1 as intervening be-
tween membrane insertion and respiratory complex assembly
are two complexes constituted of members of the mitochon-
drial triple-A family. The ¢rst complex contains Afg3p and
Rca1p, the second Yme1p. All three proteins belong to the
metalloprotease sub-group of this family of ATPases and are
capable of the degradation of incomplete or unassembled
newly synthesised mitochondrial translation products [20,21].
Additionally, at least the Afg3/Rca1 complex (which is formed
in the presence of ATP and has a molecular mass around 850^
1000 kDa [22,23]) plays a chaperone-like role in respiratory
complex assembly. It may possibly achieve this by putting
newly synthesised proteins on hold until partner proteins be-
come available, i.e. by acting as a ‘holdase’ rather than a
‘foldase’ (cf. [24]).
The importance of the metalloprotease sub-group of triple-
A proteins for mitochondrial assembly is emphasised by re-
cent studies, which have resulted in the identi¢cation of the
gene responsible for an autosomal recessive form of hereditary
spastic paraplegia (HSP [25]). This gene encodes paraplegin, a
triple-A protein only distantly related to other members of the
metalloprotease sub-group. HSP is characterised by progres-
sive weakness and spasticity of the lower limbs due to degen-
eration of the corticospinal axons, with patients showing wide
variation in the severity of clinical defects. Why the loss of an
apparently ubiquitous protein like paraplegin should primar-
ily a¡ect speci¢c axonal populations is as yet unclear. It may
be that these cells, which are among the longest in the human
body, are extremely sensitive to loss of either assembly or
protease functions provided by paraplegin.
Of great interest is the question how degradative and as-
sembly functions of this ‘quality control’ machinery are bal-
anced. Some useful hints on this point may come from a
comparison of the functionally homologous FtsH complex
in E. coli, where a complex of the related proteins H£C and
H£K exerts a negative e¡ect on the degradative activity of
FtsH [26]. Yeast contains two proteins with clear sequence
similarity to H£C and a lower, but signi¢cant similarity to
H£K. These two proteins (Phb1 and Phb2) show extensive
homology to mammalian prohibitins. Like the mammalian
proteins, they have a mitochondrial location [27,28], display-
ing a ¢rm association with the inner membrane, where they
together form large complexes with molecular mass of 900^
1100 kDa (L.G.J. Nijtmans and M. Artal-Sanz, unpublished
observation). Unlike the H£C/K complex and FtsH, there is
as yet no evidence for a direct interaction between Phb1/2 and
Afg3/Rca1 (L.G.J. Nijtmans and M. Artal-Sanz, unpublished
observation). However, careful in vitro pulse-chase labelling
studies on mitochondrial translation products (L. de Jong and
H. van der Spek, unpublished observation) suggest some kind
of functional interaction does exist, which serves to stabilise
unassembled polypeptides.
7. Complex assembly
Compared with the intricacy of detail provided by the com-
plete 3D structures of the bovine mitochondrial F1-ATP syn-
thase, cytochrome c oxidase and bc1 complexes [29^31], very
little is known in any organism of the processes involved in
their assembly. In yeast, analysis of mutants disturbed in as-
sembly has led to the identi¢cation of a number of nuclear
gene products, many of which are indicated in Fig. 1. In
contrast to factors involved in translational controls, a wide-
ranging evolutionary conservation is often observed, suggest-
ing a dependence on basic mechanisms for achieving protein
folding, stabilisation, membrane translocation and co-factor
addition. For some of these factors (like (Cox10p/Cox11p
(haem farnesylation [32]), Sco1p/Cox17p (Cu-addition [33]),
Oxa1p (protein £ippase [34,35]), the involvement can be de-
¢ned in these broad terms; exact mechanisms are still obscure.
For others (the majority), little can be said beyond that they
play roles at some stage after synthesis of the mitochondrially
encoded subunits. More detailed demarcation has so far been
e¡ectively hampered by the remarkable ability of the quality
control system to recognise and initiate degradation of parti-
ally or incorrectly assembled complexes. Progress in this area
may be achievable by study of double mutants in which, in
addition to the loss of a speci¢c assembly factor, the degra-
dative activities of the Afg3p, Rca1p and Yme1p metallopro-
teases have been eliminated by mutation. This is unlikely to
eliminate all turnover of unassembled subunits, since other
proteolytic activities have been described in yeast mitochon-
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dria [36,37], but it may be enough to allow accumulation of
distinctive assembly intermediates to detectable levels.
8. Genomic aspects
How many proteins does it take to make a working mito-
chondrion? In yeast, most of the 340 or so known mitochon-
drial proteins were identi¢ed by biochemical and/or genetic
approaches that were based on prior notions of activity or
(respiratory-de¢cient) phenotype. With still somewhere
around 2100 orfs of unknown function in the yeast genome,
there is still scope for the discovery of new genes involved in
mitochondrial assembly or function. Disruptants for each of
6100 genes are gradually emerging from ongoing systematic
gene function programmes and a screen for those displaying
respiratory de¢ciency will undoubtedly turn up additional
candidates. However, working on the assumption that a num-
ber of genes may have so far escaped attention because their
mutation or loss of function results in either too mild, too
severe or complex a phenotype, alternatives should also be
considered.
Within EUROFAN, the EU consortium engaged in the
study of gene function on a genome-wide scale in yeast, use
has been made of the PSORTII programme [38] to predict
sub-cellular location. Of some 50 orfs examined by this ap-
proach, just over 30 have been assigned to mitochondria by
(immuno-)£uorescence, or fractionation and Western blotting
of the GFP- or HA-tagged fusion protein (G.-J. Hakkaart,
C.J. Herbert and R.J. Schweyen, unpublished observatopm).
However, as the perfect algorithm for prediction of all classes
of mitochondrial protein does not and may never exist, an-
other in silico approach worth consideration is one based on
patterns of co-expression as revealed by a combination of
micro-array hybridisation with statistical cluster analysis [39].
Such an analysis, although primarily of value in the identi-
¢cation of groups of co-regulated genes, of shared promoter
elements and thereby also of common transcription control
proteins, has potential for the assignment of novel proteins
to functional groups. Studies carried out so far are based on
limited amounts of data and on relatively unsophisticated
clustering algorithms. Nevertheless, it is striking how much
information on gene function and even physical interaction
between gene products can be gleaned from them [40], thereby
opening up new and exciting avenues for further experimen-
tation.
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